Optimal population-level deployment of artemisinin combination therapies

Tran Dang Nguyen; Piero Olliaro; Arjen M. Dondorp; J. Kevin Baird; Ha Minh Lam; Jeremy Farrar; Guy Thwaites; Sir Nicholas White; Maciej F. Boni

Optimal population-level deployment of artemisinin combination therapies

Tropical Medicine & International Health 20: 182-182

Article 2015 English

Related publications

Letter2020

Triple artemisinin-based combination therapies for malaria: proceed with caution – Authors' reply

Rob W. van der Pluijm, Aung Pyae Phyo, Dysoley Lek, Sir Nicholas White, Arjen M. Dondorp

The Lancet

Article2015

Optimum population-level use of artemisinin combination therapies: a modelling study

Tran Dang Nguyen, Piero Olliaro, Arjen M. Dondorp, J. Kevin Baird, Ha Minh Lam, Jeremy Farrar, Guy Thwaites, Sir Nicholas White, Maciej F. Boni

The Lancet Global Health

Article2007

Modelling antimalarial drug resistance amd the cost-effectiveness of different coverage rates with Artemisinin Combination Therapies (ACTs)

Shunmay Yeung, Wirichada Pongtavornpinyo, Ian M. Hastings, Anne Mills, Sir Nicholas White

American Journal of Tropical Medicine and Hygiene

Letter2022

Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?

Rob W. van der Pluijm, Thomas J. Peto, Mainga Hamaluba, James J. Callery, Rupam Tripura, Sir Nicholas White, Arjen M. Dondorp

The Lancet Infectious Diseases

Article2022

TCT-304 Non-Invasive Assessment of Microvascular Dysfunction After Optimal Coronary Artery Stent Deployment; Insight From Acetyl Salicylic Elimination Trial (ASET) Japan

Shinichiro Masuda, Jinying Zhou, Shigetaka Kageyama, Kai Ninomiya, Nozomi Kotoku, Pruthvi Chenniganahosahalli Revaiah, Yoshinobu Onuma, Patrick W. Serruys

Journal of the American College of Cardiology

Optimal population-level deployment of artemisinin combination therapies

Abstract

Discussion(0)

Related publications

Triple artemisinin-based combination therapies for malaria: proceed with caution – Authors' reply

Optimum population-level use of artemisinin combination therapies: a modelling study

Modelling antimalarial drug resistance amd the cost-effectiveness of different coverage rates with Artemisinin Combination Therapies (ACTs)

Is triple artemisinin-based combination therapy necessary for uncomplicated malaria?

TCT-304 Non-Invasive Assessment of Microvascular Dysfunction After Optimal Coronary Artery Stent Deployment; Insight From Acetyl Salicylic Elimination Trial (ASET) Japan